Ifeoma Felicia Chukwuma

Ifeoma Felicia Chukwuma

Auto-generated profile, based on publicly available information

Ifeoma Felicia Chukwuma

Department of Biochemistry Faculty of Biological Sciences Nsukka Nigeria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in Engineering Reports
Verified
Journal Article
Open access
VAVictor Onukwube Apeh
Victor Onukwube Apeh
Kennedy Chinedu OkaforKennedy Chinedu Okafor
Kennedy Chinedu Okafor
ICIfeoma Felicia Chukwuma
Ifeoma Felicia Chukwuma
HUHenrietta Onyinye Uzoeto
Henrietta Onyinye Uzoeto
TCTitus Ifeanyi Chinebu
Titus Ifeanyi Chinebu
OAOkoronkwo Chukwunenye Anthony
Okoronkwo Chukwunenye Anthony
The emergence of resistance to current antimalarial drugs poses a significant challenge in the fight against malaria. This study aimed to investigate the in vivo antiplasmodial potential of the aqueous extract of fresh and dried leaves of A3 in Plasmodium berghei‐infected (P. berghei) mice. A 4‐day suppressive test was conducted, with infected BALB/c mice receiving artesunate and A3 extracts. The results showed that the tested doses of A3 attenuated the elevation of parasitemia induced by P. berghei, particularly at the dose of 400 mg/kg, and improved hematological indices. Computational techniques, including molecular docking, binding free energy calculations, and ADMET predictions, identified several bioactive compounds in A3 with promising inhibitory potential against lysyl‐tRNA synthetases and Dihydrofolate reductase (DHFR), the crucial enzymes targeted by antimalarial drugs. In this paper, Friedelin, Bauerenol, Epifriedelanol, Alpha‐Amyrenone, Stigmasterol, and beta‐Amyrin acetate were top‐ranked, having docking scores from −10.6 to −9.9 kcal/mol, compared with the −9.4 and −7.1 kcal/mol demonstrated by artesunate and chloroquine, respectively, as standard ligands. Also, it was shown that docking score from the Lysyl‐tRNA protein target (4YCV) ranged from −9.5 to −7.8 kcal/mol in comparison to artesunate (8.1 kcal/mol) and chloroquine (5.6 kcal/mol). The results suggest that the identified compounds in A3 could serve as potential candidates for the development of new anti‐malarial agents.